Xiaobo Cao

Statistics

Publications

Citations

189

H-Index

Active since

2015

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Xiaobo Cao is an author at The University of Texas MD Anderson Cancer Center specializing in non-small cell lung cancer treatment, non-small cell lung cancer therapy, and oncology.

ORCID

Publications per year

2015–2024

Publications

Auranofin-mediated inhibition of PI3K/AKT/mTOR axis and anticancer activity in non-small cell lung cancer cells

Hongyu Li, Jing Hu, Shuhong Wu et al. · Oncotarget · 2015 · 147 citations · Full text

Medicine, Oncology, Pharmacology +16

TUSC2(FUS1)-erlotinib Induced Vulnerabilities in Epidermal Growth Factor Receptor(EGFR) Wildtype Non-small Cell Lung Cancer(NSCLC) Targeted by the Repurposed Drug Auranofin

Xiaobo Cao, Mourad Majidi, Meng Feng et al. · Scientific Reports · 2016 · 27 citations · Full text

Medicine, Oncology, Pharmacology +17

Enhanced Linear Active Disturbance Rejection Speed Control of IPMSM Based on Interference Differential Compensation and Cascaded Linear Extended State Observer

Yangyang Cui, Zhonggang Yin, Xiaobo Cao et al. · IEEE Transactions on Power Electronics · 2024 · 15 citations

Engineering, Autonomous Systems, Electric Machines +15

1–3 of 3